Tessa Therapeutics Pte Ltd
8 Temasek Boulevard
#24-02 Suntec Tower 3
Tel: 65 6384 0755
About Tessa Therapeutics Pte Ltd
Tessa Therapeutics is a clinical stage biopharmaceutical company with the scientific vision of revolutionizing the treatment of cancer by redirecting the body’s potent anti-viral immune response to recognize and kill cancer cells. Tessa’s core virus-specific T cell (VST) platform has shown compelling results in the treatment of solid tumors, and the company is building a portfolio of therapies addressing a wide range of tumors by combining the qualities of its T cell platform with complementary technologies.
CEO: Andrew Khoo
COO: John Ng
CFO: Desmond Lim
47 articles about Tessa Therapeutics Pte Ltd
Distinguished Breast Cancer Expert, Dr. George W. Sledge, Jr., M.D., to join the Board of Tessa Therapeutics
Dr. George W. Sledge, Jr., M.D., is Professor and Chief of Medical Oncology at the Stanford University Medical Center
BioSpace Movers and Shakers for Dec. 3
12/3/2018Biotechs and pharmas strengthened their leadership teams with these appointments. Find news from Mersana, Foamix, Allergan, and more.
Vineti™ to Partner With Tessa Therapeutics™ to Advance and Scale Cancer Immunotherapies World-Wide
Vineti’s software platform for cell therapy workflows will support Tessa’s Asia operations and global capabilities, help scale transformative research in personalized cell therapies for solid tumors, and transition to commercial operations
St. Jude Children's Research Hospital and Tessa Therapeutics Announce Strategic Collaboration
The collaboration between St. Jude and Tessa aims to advance cellular immunotherapy treatments for childhood cancer
Tessa Therapeutics Announces Opening of Recruitment Sites Across the United States for its Phase III Nasopharyngeal Cancer Immunotherapy Trial
The first T cell infusion under the trial in the U.S. was carried out at City of Hope National Medical Center.
The $80M financing round led by Temasek and joined by EDBI, Karst Peak Capital, Heliconia, Heritas and other investors.
Tessa Therapeutics Appoints Mr. Desmond Lim as CFO
Mr. Lim has over 25 years of finance experience and has held multiple senior executive roles in the recent decade.